Cargando…
Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide. During the early stages of the disease, HCC can be treated with surgery or radiofrequency procedures. Most HCC cases are discovered at later stages when these therapies cannot be used, and a treatmen...
Autores principales: | Alghamdi, Saad, Al-Hamoudi, Waleed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648843/ https://www.ncbi.nlm.nih.gov/pubmed/37958291 http://dx.doi.org/10.3390/cancers15215115 |
Ejemplares similares
-
Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View
por: Abdelrahim, Maen, et al.
Publicado: (2022) -
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
por: Ouranos, Konstantinos, et al.
Publicado: (2022) -
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020) -
The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
por: Lee, Matthew Man Pok, et al.
Publicado: (2023) -
Coincidental Occurrence of Hepatocellular Carcinoma and Cholangiocarcinoma (Collision Tumors) After Liver Transplantation: A Case Report
por: Al Hamoudi, Waleed, et al.
Publicado: (2012)